Nature S Sunshine Products Inc Receivables Turnover Ratio (NATR), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Nature s Sunshine Products inc   (NASDAQ: NATR)
 

Nature S Sunshine Products Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Nature S Sunshine Products Inc 's ability to collect accounts receivable sequentially worsen to 39.24, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Average collection period, for Nature S Sunshine Products Inc 's accounts receivable remained unchanged at 9 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 24 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 194 to 244.

What is Receivable Turnover Ratio?
What is Nature S Sunshine Products Inc Selling?


What is Receivable Turnover Ratio?





NATR Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 6.39 % 9.95 % -9.23 % 32.63 % 15.4 %
Y / Y Revenue Change 2.35 % 8.33 % 4.8 % 12.56 % 4.02 %
Receivable Turnover Ratio (TTM) 39.24 39.69 39.85 38.67 40.58
NATR's Total Ranking # 244 # 194 # 198 # 91 #
Accounts Receivable average collection period days 9 9 9 9 9
Seq. Receivable Change 10.46 % 45.88 % -43.09 % 16 % 14.16 %
Seq. Revenue Change -4.09 % -2.25 % -2.55 % 12.03 % 1.51 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 25
Overall Market # 244

Receivable Turnover Ratio Statistics
High Average Low
52.59 41.08 28.13
(Dec 31 2020)   (Sep. 30, 2014)






Financial Statements
Nature S Sunshine Products Inc 's Accounts Receivable $ 14 Millions Visit NATR's Balance sheet
Nature S Sunshine Products Inc 's Sales TTM $ 492 Millions Visit NATR's Income Statement
Sources of NATR's Revenues Visit NATR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NATR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NATR's Growth Rates NATR's Roa NATR's Inventory Turnover Ratio NATR's Dividend Comparisons
NATR's Profitability Ratios NATR's Roi NATR's Asset Turnover Ratio NATR's Dividend Growth
NATR's Valuation Ratios NATR's Roe NATR's Financial Strength Ratios NATR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Assembly Biosciences Inc   94.77 $ 74.845  Millions$ 0.790  Millions
Earth Science Tech Inc   88.94 $ 34.647  Millions$ 0.390  Millions
Sbc Medical Group Holdings Incorporated  86.85 $ 173.713  Millions$ 2.000  Millions
Lenz Therapeutics Inc   77.11 $ 21.475  Millions$ 0.279  Millions
Airsculpt Technologies Inc   64.88 $ 150.724  Millions$ 2.323  Millions
Arrowhead Pharmaceuticals Inc   60.05 $ 669.495  Millions$ 11.149  Millions
Fortrea Holdings Inc   56.65 $ 2,676.500  Millions$ 47.250  Millions
Humacyte Inc   52.69 $ 30.074  Millions$ 0.571  Millions
Brookdale Senior Living Inc   47.66 $ 3,050.697  Millions$ 64.009  Millions
National Vision Holdings Inc   44.61 $ 2,033.426  Millions$ 45.586  Millions
Meiragtx Holdings Plc  40.72 $ 397.501  Millions$ 9.762  Millions
Bioadaptives Inc   35.76 $ 0.026  Millions$ 0.001  Millions
Lifevantage Corp  35.05 $ 180.947  Millions$ 5.162  Millions
Innovative Eyewear Inc   31.49 $ 3.412  Millions$ 0.108  Millions
Mangoceuticals Inc   31.43 $ 0.315  Millions$ 0.010  Millions
Cv Sciences Inc   31.22 $ 12.066  Millions$ 0.387  Millions
Jaguar Health Inc   30.23 $ 27.815  Millions$ 0.920  Millions
Invo Fertility Inc   30.20 $ 7.531  Millions$ 0.249  Millions
Metagenomi Therapeutics Inc   25.05 $ 13.561  Millions$ 0.541  Millions
Sonida Senior Living Inc   22.59 $ 525.973  Millions$ 23.283  Millions
U S Physical Therapy Inc  22.40 $ 812.203  Millions$ 36.251  Millions
Hims and Hers Health Inc   19.65 $ 2,578.494  Millions$ 131.228  Millions
Lipocine Inc   18.36 $ 1.569  Millions$ 0.085  Millions
Nrx Pharmaceuticals Inc   17.25 $ 3.394  Millions$ 0.197  Millions
Polomar Health Services, Inc.  17.19 $ 3.172  Millions$ 0.185  Millions
Anika Therapeutics Inc   16.70 $ 121.370  Millions$ 7.266  Millions
Vireo Growth Inc.  16.69 $ 511.706  Millions$ 30.659  Millions
Neuraxis Inc   15.53 $ 5.316  Millions$ 0.342  Millions
Agenus Inc  15.44 $ 132.693  Millions$ 8.595  Millions
Longeveron Inc   15.03 $ 1.187  Millions$ 0.079  Millions

Date modified: 2026-09-05T12:06:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.